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1. Introduction
This report is the first draft of our evaluation of the community rapid HIV testing pilot
interventions funded by gsk and delivered by Terrence Higgins Trust (THT) with
collaborators in three genito-urinary medicine (GUM) clinics. The sites were THT West in
Bristol; THT Yorkshire in Leeds; and London Lighthouse South (in Waterloo, South Central
London). Given that several similar interventions exist we always use the fasTest brand
name developed by THT to refer to the intervention. 
This report is intended for the Terrence Higgins Trust and collaborators. We report here all
that is known about the intervention from the evaluation to date. In this draft we have not
invested substantially in describing the context of the intervention or the academic
literature that underpins some of the assumptions made. 
The following report describes the data collected using the three broad methods outlined
in our original bid. Chapter 2 describes our collaborative monitoring of service provision
and follow-up through HIV care services. Chapter 3 describes all the findings from our
self-complete 4 page questionnaire completed by 593 fasTest users in the gsk sites.
Chapter 4 describes our difficulties with the intended follow-up telephone interviews with
those tested POSITIVE in fasTest. Chapter 5 provides an interim evaluation summary
against the seven standard elements of an evaluation outlined in our initial bid. 
Terrence Higgins Trust currently describe their aims in delivering this intervention as: 
• Reduce levels of undiagnosed HIV
• Provide greater access and choice for individuals
• Provide results at point of testing
• Establish a fast-tracking procedure into treatment & care for those testing positive
Our initial aims for this evaluation (taken from our bid) were: 
• Describing the entire population who tested at each site, including demographic
profiles, sexual history and sexual health needs.
• Identifying how the population who tested at each site might vary from attendees
of other clinical sexual health services. The key aim will be to assess whether (and
why) target groups are more likely to access services based in community settings
compared to other settings.
• Evaluating the acceptability of the interventions to Gay and African communities
(from surveys and interviews). 
• Evaluating the effectiveness of the interventions in screening an at-risk population
including their capacity to identify new cases of HIV. 
Interventions to diagnose HIV are already in operation and this new intervention should
be compared to these. In the Milne Centre for Sexual Health @ Bristol Royal Infirmary (one of
the host GUM clinics) the same 4 page semi-structured questionnaire was used with 100
consecutive attenders presenting for HIV testing in the main out-patients clinics. A
separate report will be available comparing these recruits with those from THT West in
Bristol. 
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2. gsk fasTest monitoring data
2.1 Organisation of fasTest sites and the evaluation
Terrence Higgins Trust established three pilot fasTest sites with gsk funding. Each was
intended to run for 12 months including 6 months of evaluation. The table below
summarises the site of the clinic; the clinical collaborators; day and time of the clinic; the
date it started and the dates the evaluation started and closed. 
gsk funded pilot sites BRISTOL
THT
West
LEEDS
THT
Yorkshire
LONDON
Lighthouse
South
Clinic providing satellite
and providing follow-up 
HIV care
Milne Centre for
Sexual Health @
Bristol Royal Infirmary
Centre for Sexual
Health @ Leeds
General Infirmary
Caldecot Centre
@ Kings College
Hospital
Clinic day and time Monday
17.00 - 19.30
Wednesday
17.30 - 20.30
Thursday
17:00 – 20:00
Priority TARGET groups over-serve
Africans &
 Gay men
over-serve
Africans &
Gay men
over-serve
Gay men
Pilot STARTED 38284 38328 38315
Clinic status on 16-03-06 ongoing ongoing ongoing
Evaluation STARTED 38480 08-June-05 9-June-05
Evaluation CLOSED 38655 38706 38700
The closure dates for the evaluation period (from 31 October to 21 December) mark the
point from which fasTest sites shifted to funding other than that provided for the initial
pilot. Given rules governing Research Ethics Committees all evaluation activity had to stop
at this point. All fasTest sites ran for at least a year in the pilot phase.
2.2 FasTest service delivered and numbers of attenders and tests
The table below summarises the number of sessions and hours of service delivered in each
site; the total numbers of attenders and numbers of tests, 
Service delivery during
evaluation period
BRISTOL
THT
West
LEEDS
THT
Yorkshire
LONDON
Lighthouse
South
All
gsk
sites
SESSIONS delivered 23 29 25 77
SESSIONS not delivered 4 0 3 7
TOTAL HOURS of service 69 87 75 231
CLINICAL hours delivered 176 261 150 587
TOTAL No. attenders 139 256 283+ 678+
TOTAL No. of tests 133 246 283 662
Average tests per session 5.8 8.5 11.3 8.6
Av. tests per clinical staff hour 0.76 0.94 1.89 1.13
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During the evaluation period 77 fasTest sessions were delivered, 29 in Leeds; 25 in
Lighthouse South and 23 in Bristol. These 77 sessions amounted to 231 hours of opening
and 587 clinical staff hours of service delivered. Between sites, clinic opening hours varied
as did the volume of staff present (Leeds and Bristol always had 3 clinical staff present
compared to 2 in Lighthouse South). 
During the evaluation period at least 678 people attended the service (attendance data
was not available for Lighthouse South) and 662 HIV tests were undertaken. The
outcomes of HIV testing and details on entry into care are covered in section 2.5. Not
every attendance was from a different person, with some people returning for second tests
within the pilot period. This was especially common when a person attended after a
specific risk for which they were still in the window period - they were usually tested and
asked to return when they fell outside the window period.
The average (mean) number of tests per session was 8.6 with a range from 5.8 in Bristol
to 11.3 in Lighthouse South. Some of this variation was a consequence of the length of
clinic opening (Bristol was open for a maximum of 2½ hours but the other sites were open
for 3 hours per week) and volume of staff in attendance (Leeds and Bristol always had 3
clinical staff in attendance compared to 2 in Lighthouse South). 
However, none of the clinics ran at full capacity for the pilot period and managing demand
was problematic at periods in all sites. Overall, on average 1 HIV test was delivered for 53
minutes of clinical staff time with a range from 79 minutes of clinical staff time per test in
Bristol; 64 minutes in Leeds and 32 minutes in London Lighthouse South. 
2.3 Evaluation response rates 
The table below outlines the response rates for participation in our self-completion survey
(see chapter 3). The overall net response rate was 89.6% with very minor variation
between the three sites. 
Evaluation response rates BRISTOL
THT
West
LEEDS
THT
Yorkshire
LONDON
Lighthouse
South
All
gsk
sites
TOTAL No. of tests 133 246 283 662
No. of evaluation forms received 117 225 258 600
gross RESPONSE RATE 88.0% 91.5% 91.2% 90.6%
Evaluation forms in analysis 117 222 254 593
net RESPONSE RATE 88.0% 90.2% 89.8% 89.6%
In what follows 593 questionnaires are included in the analysis. The 7 questionnaires that
are excluded include 6 that were returned blank and one from a person who was adjudged
ineligible for the intervention because she had previously received a positive HIV test
result. After exclusions the overall response rate is 89.6% with a range from 88.0% in
Bristol to 90.2% in Leeds. 
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2.4 Testing positive for HIV in fasTest 
Section 3.5.1 outlines HIV prevalence among the 17 fasTest users that had a new HIV
diagnosis and completed the evaluation questionnaire. This following table outlines all
positive tests recorded in the evaluation period and is taken from monitoring data. 
Of the 662 HIV tests conducted during the evaluation period there were 20 HIV positive
diagnoses (3.0% prevalence overall). In the table below is a summary of data gathered on
testing and HIV test outcomes from the monitoring data.
HIV positive diagnoses
during evaluation period
BRISTOL
THT
West
LEEDS
THT
Yorkshire
LONDON
Lighthouse
South
All gsk
sites
TOTAL of HIV tests 133 246 283 662
TOTAL of positives 4 8 9 21
FALSE positives 0 0 0 0
PRIOR positives (ineligible) 0 1  0 1
Total of VALID positives 4 7 9 20
NOT CONFIRMED positives 1 1 1 3
CONFIRMED on serology 3 6 8 17
FOLLOW-UP serology data 3 6 5 14
HIV prevalence
(confirmed)
3.0%
(2.3%)
2.8%
(2.4%)
3.2%
(2.8%)
3.0%
(2.6%)
Among the 21 positive test results there was 1 prior positive that was ineligible for the
service (in Leeds). She did not declare her HIV infection to staff  before using fasTest (but
recorded it on her evaluation form). She was excluded from the data presented in chapter
3. Clinical staff had some suspicion that the solitary unconfirmed positive in Lighthouse
South might have known already known of her HIV infection but since there was no proof
she remains in the data set. Through the course of the entire intervention, prior positives
occurred in all sites and for a wide variety of reasons. With such a low-threshold, open-
access service it is essential to plan for their attendance. 
Of the 20 remaining positive tests (3.0% prevalence) 17 were confirmed on serology and
3 were not (one in each site). None of the confirmed 17 positive tests proved false on full
serology. 
There was an overall confirmed HIV prevalence of 2.6% across all three sites with
variation from 2.3% in Bristol, through 2.4% in Leeds to 2.8% in London Lighthouse
South.
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2.5 HIV serology and care after testing positive in fasTest 
The table below summarises the follow-up serology results of positives first diagnosed
with HIV in fasTest and where they sought subsequent HIV monitoring and treatments. 
Follow-on serology and entry
to HIV care during evaluation
period
BRISTOL
THT
West
LEEDS
THT
Yorkshire
LONDON
Lighthouse
South
All
gsk
sites
Total of HIV TESTS 133 246 283 662
Total of VALID positives 4 7 9 20
Entering
HIV care
@ host clinic 3 5 5 13
known elsewhere 0 1 2 3
NOT known 1 1 2 4
FOLLOW-UP serology data 3 6 5 14
Initial CD4 mean 439 520 470 485
stand. dev 29 320 316 267
median 442 507 525 458
range 409-466 11–946 24-832 11-946
CD4 % mean 31 none
received
21 25
stand. dev. 8 10 10
median 33 23 24
range 22-38 38867 5-38
initial viral
load
mean 56183 68820 150045 97144
stand. dev 70370 23361 144272 99323
median 33017 69300 140000 69300
range 316-
135,216
44,000-
100,000
228-
367,000
228-
367,000
As reducing the length of time between HIV infection and diagnosis was one central
reason for the development of these new community interventions, a key indicator of
success (relative to existing HIV diagnosis interventions) was intended to be differences in
disease progression among people diagnosed with HIV in fasTest compared to standard
GUM. With follow-up data from only 14 (of 20) people newly diagnosed with HIV in these
three sites, it is not possible to address comparative questions of disease progression.
As screening interventions are only as useful as the treatment interventions which follow
them, the referral pathways between the two are described above. For 16 of the 20 valid
positives we have information on where they received subsequent HIV monitoring and
care. Thirteen of these 20 entered care in the host clinic associated with the fasTest site
where they were diagnosed, and three were known to have entered care elsewhere.
Among the four where no detail of follow-on HIV care was known, three did not have a
confirmatory blood test (one in each site) and one from Lighthouse South London returned
to Kings College for confirmation but then moved abroad to live. 
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3. FASTEST USERS SURVEY
3.1 DEMOGRAPHIC CHARACTERISTICS OF USERS
3.1.1 Gender 
Five in every six (83.6%, n=496) respondents using fasTest in the three gsk funded pilot
sites were males. This included three quarters of those using THT West in Bristol (77.8%,
n=91); 82.9% (n=184) of those using THT Yorkshire in Leeds and 87% (n=221) of those
using Lighthouse South London. One in six (16.4%, n=97) of all testers were females:
22.2% (n=26) of those using Bristol; 17.1% in Leeds (n=38) and only 13.0% (n=33) of
those using fasTest in Lighthouse South. 
Gender by fasTest site
(n=593, missing 0)
% All
Testers
n=593
% THT
West
n=117
% THT
Yorkshire
n=222
% Lighthouse
South
n=254
Male 83.6 77.8 82.9 87
Female 16.4 22.2 17.1 13
3.1.2 Sexual activity and identity
All respondents were asked What term do you usually use to describe yourself sexually?
and offered four responses: Heterosexual or straight; Gay or Lesbian; Bisexual and other.
Very few (<1%) ticked other. Among the other identities those that specified queer were
recoded as Gay and those that stated normal were recoded as heterosexual. However, the
majority of the others did not specify any alternate term and were recoded as missing.
Sexual identity by fasTest
site (n=579, missing 14) 
% All
Testers
n=579
% THT
West
n=115
% THT
Yorkshire
n=213
% Lighthouse
South
n=251
Heterosexual (straight) 48.5 54.8 55.4 39.8
Gay or Lesbian 43.7 39.1 37.1  51.4
Bisexual 7.8 6.1 7.5 8.8
In addition all respondents were asked In the last year, have you had sexual relations
with... and offered the responses Both men and women; Women only; Men only; and No
one (neither men nor women). 
Gender of sexual partners
in the last year by fasTest
site (n=570, missing 23)
% All
Testers
n=331
% THT
West
n=114
% THT
Yorkshire
n=215
% Lighthouse
South
n=241
Men only 58.1 59.6 50.2 64.3
Women only 31.6 29.8 37.2 27.4
Both men and women 8.6 7.9 9.8 7.9
No one 1.8 2.6 2.8 0.4
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Using these two variables in addition to gender we can allocate 99.7% (n=591) of all
fasTest users to one of four groups: heterosexual females (15.4%, n=91); heterosexual
males (33.0%, n=195); Gay or Bisexual or homosexually active males (50.6%, n=299);
Lesbian, Bisexual or homosexually active females (1.0%, n=6). Where respondents did
not indicate a sexual identity (n=14, 2.4% of all) but did indicate the gender of their
sexual partners (n=12, 2.0% of all) they have been allocated to a group according to
sexual activity in the last year. 
Sexual identity and gender of
partners in the last year by
fasTest site
(n=591, missing 2) 
% All
Testers
n=591
% THT
West
n=117
% THT
Yorkshire
n=221
% Lighthouse
South
n=253
MALE: Gay, Bisexual or HAM 50.6 45.3 42.1 60.5
MALE: Heterosexual 33 32.5 40.7 26.5
FEMALE: Lesbian or Bisexual 1 0.9 2.3 0
FEMALE: Heterosexual 15.4 21.4 14.9 13
Among the 97 females in this whole sample, 4 identified as Lesbian and 2 as Bisexual.
Among these six females 3 only had sex with a man in the last year; and one each had
sex with no one, women only and both men and women. Among the females that
identified s heterosexual one had sex with women only and another had sex with both
men and women in the last year. Five had sex with no one. Given the fluid relationship
between sexual identity and activity and the very small sample sizes all females will be
presented together in all that follows.
As the table above demonstrates sexual identity and gender of partners varied by fasTest
site. In Lighthouse South the service was intended to over-serve only Gay and Bisexual
men as opposed to Gay men and African people in Leeds and Bristol. This is reflected in a
higher proportion of all users being Gay or Bisexual in Lighthouse South (60.5%)
compared to THT West (45.3%) or THT Yorkshire (42.1%). In the two sites intended to be
over-serve both Gay men and Black Africans the majority of all users were heterosexual
((53.9% in THT West and 55.6% in THT Yorkshire). 
3.1.3 Ethnicity
The Lighthouse South London site was targeted at Gay and Bisexual men with no
aspiration to over-serve any specific ethnic group. Both THT West and THT Yorkshire
sought to over-serve Black Africans. All testers were asked What is your ethnic group? and
required to indicate one of the 16 options from the 2001 UK Census (Office of National
Statistics 2005). Other answers were allocated to categories according to Office of
National Statistics instructions. Ethnic group data was missing for 1 person (0.2%). The
following table shows the number of testers from each ethnic group by fasTest site. 
The overall proportion that were White British was 64.5% (n=382), though this varied
from 53.4% at Lighthouse South, to 72.6% in Bristol and 73.0% in Leeds. The proportion
that were from ethnicities other than white (6.9% in Bristol; 20.2% in Leeds; and 22.1%
in Lighthouse South) also varied substantially by site. Excepting Bristol, this proportion
was substantially larger than the 2001 UK Census estimate of 7.9% of people resident in
the UK not being White, suggesting some success in ethnic-specific targeting in Leeds.
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Ethnic group by fasTest site
(n=592, missing 1)
% All
Testers
n=592
% THT
West
n=117
% THT
Yorkshire
n=222
% Lighthouse
South
n=253
White British 64.5 72.6 73 53.4
Irish 2.2 1.7 1.4 3.2
Other White 14.9 18.8 5.4 21.3
Black /
Black
British
Caribbean 2.2 1.7 3.2 1.6
African  6.1 1.7 8.1 6.3
Asian /
Asian
British
Indian 2.4 0.9 0.9 4.3
Other Asian 3.5 0.9 4.5 4
Dual /
mixed 
White & Black Caribbean 0.8 0.9 0.9 0.8
White & Black African 0.3 0 0.5 0.4
White & Asian 0.5 0 0 1.2
Other Mixed 0.3 0 0.9 0
All other ethnicities 2.2 0.9 1.4 3.6
Leeds and Bristol sites were intended to over-serve Black Africans irrespective of sexual
activity or identity, in addition to over-serving Gay and Bisexual men. Compared to
Bristol, Leeds was somewhat successful at over serving Black African (8.1% v 1.7%) and
Black Caribbean (3.2% v 1.7%) people. It is worth noting also, that Lighthouse South
London also saw a reasonable number of Black African (6.3%) and Black Caribbean
(1.6%) testers, the majority of whom were heterosexual. 
The ethnicity of testers also varied by gender and sexual identity. Compared to males,
female testers were significantly more likely to be Black African (14.4% v 4.4%) and less
likely to be White British (50.5% v 67.3%). Among males, heterosexuals and Gay and
Bisexual men were equally likely to be White British (66.5% v. 67.9%) but heterosexuals
were less likely to be White other (12.4% v 18.4%) and more likely to be Black African
(8.2% v 2.0%).  
Ethnicity by gender and
sexuality
(n=590, missing 3) 
All
Testers
n=590
All
Males
n=495
All
Females
n=97
Gay or Bi
Males
n=299
Hetero
Males
n=194
White British 64.6 67.3 50.5 67.9 66.5
White other 16.9 16.2 21.6 18.4 12.4
Black African  6.1  4.4 14.4 2 8.2
Black Caribbean 2.2 2  3.1 2 2.1
All others 10.2 10.1 10.3 9.7 10.8
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3.1.4 Country and continent of birth
All testers were also asked their country of birth. Country of birth was missing for 9 
testers (1.5%). Overall, just under three quarters (72.3%) indicated they were born in the
UK, of which 91.9% were born in England. Apart from those born in the UK, the majority
were born in a European country other than the UK (10.7%, listing 20 different countries);
or in Africa (6.3%, n=42, listing 19 different countries). The following table shows the UK
and continents of birth, by fasTest site. 
Country / continent of
birth by fasTest site 
(n=589, missing 4)  
% All
Testers
n=589
% THT
West
n=116
% THT
Yorkshire
n=220
% Lighthouse
South
n=253
United Kingdom 72 75.9 79.1 64
Other European 10.7 12.9  6.4 13.4
Africa  6.3 5.2  8.2  5.1
Asia 4.1 1.7 2.3 6.7
North & Central America
(inc. Caribbean)
3.9 0.9 2.7 6.3
South America 2.2 1.7 1.4 3.2
Australasia 0.8 1.7  0 1.2
Apart from those born in the UK, 64 other countries of birth were listed by fasTest users
across the three sites. Among these, only 6 countries accounted for more than 1% of all
respondents each. In order these were: Germany (n=15, 2.6%); USA (n=15, 2.6%);
France (10, 1.7%); Zimbabwe (9, 1.5%); Republic of Ireland (8, 1.4%); and Brazil (6, 
1.0%). 
   
Country of birth varied by gender and sexual identity in a similar pattern to ethnicity. The
proportion born in the UK was substantially higher among all males (74.0%) compared to
females (61.9%), especially among those recruited outside London. Female testers were
significantly more likely to be African born (14.4% v 4.7%). Among males, heterosexuals
and Gay and Bisexual men were equally likely to be British-born (76.6 v. 72.5%) but
heterosexuals were less likely to be from another European country (8.9% v 11.4%) and
more likely to be African born (6.3% v 3.7%).  
Continent of birth by gender
and sexuality
(n=589, missing 4)  
All
Testers
n=589
All
Males
n=492
All
Females
n=97
Gay or Bi
Males
n=298
Hetero
Males
n=192
United Kingdom 72 74 61.9 72.5 76.6
Other European 10.7 10.4 12.4 11.4  8.9
Africa  6.3 4.7 14.4 3.7  6.3
Asia 4.1 4.1 4.1 4.4 3.1
North & Central America 3.9 3.9 4.1 4 3.6
South America 2.2 2.2 2.1 2.7 1.6
Australasia 0.8 0.8 1 1.3  0
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3.1.5 Years resident in the UK
All testers were asked how long they had lived in the UK. This question was not answered
by 10 testers (1.7% of the sample). The following table shows the length of residence in
the UK by fasTest site. 
Two thirds (66.7%) of all testers indicated they had always lived in the UK. While testers
at THT Yorkshire in Leeds were more likely to have always lived in the UK (75.9%), a
quarter of them had not always done so. In THT West 64.7% of testers had always lived in
the UK and this fell to 59.8% among testers at Lighthouse South.
Years resident in the UK
by fasTest site 
(n=583, missing 10)
% All
Testers
n=583
% THT
West
n=116
% THT
Yorkshire
n=216
% Lighthouse
South
n=251
Visiting the UK 1.5 2.6 0.5 2
Less than 1 year 7.2 8.6 6.5 7.2
Between 1 & 5 years 11 7.8 9.7 13.5
Between 5 & 10 years 5.7 3.4 4.6 7.6
More than 10 years 7.9 12.9 2.8 10
always lived in the UK 66.7 64.7 75.9 59.8
Years resident in the UK varied by gender and sexual identity in a similar pattern to
ethnicity and country of birth. The proportion who had always lived in the UK was
significantly higher among males (69.8%) than females (51.0%), especially among those
recruited outside London. Among those that had not always lived in the UK, females
appear to have migrated more recently (17.5% were visiting or had been here less than a
year) than males (6.9% were visiting or had been here less than a year). Among males,
heterosexuals and Gay and Bisexual men were equally likely to have always lived in the
UK (69.4% v. 70.0%).
Continent of birth by gender
and sexuality
(n=583, missing 10) 
All
Testers
n=583
All
Males
n=487
All
Females
n=96
Gay or Bi
Males
n=293
Hetero
Males
n=193
Visiting the UK 1.5 1.2 3.1 0.7 2.1
Less than 1 year 7.2 5.7 14.6 5.1 6.7
1 - 5 years 11 10.1 15.6 10.2  9.8
5 - 10 years 5.7 5.1 8.3 5.8  4.1
10 years +  7.9  8 7.3  8.2  7.8
Always 66.7 69.8 51 70 69.4
gsk fasTest evaluation, Sigma Research: 11 of  36
3.1.6 Area of residence
Respondents were asked Which Local Authority do you live in? (who sends your household
the Council Tax bill?) and were asked to supply their postcode or town or city they lived in
if they did not know their Local Authority or the country they lived in if they were visiting
the UK. 5.9% (n=35) failed to supply any residence data. Respondents lived in all areas of
the United Kingdom and 1.5% (n=9) were visiting the UK from abroad. 
Area of residence by fasTest site
(n=558, missing 35)
% All
Testers
n=558
% THT
West
n=113
% THT
Yorkshire
n=202
% Lighthouse
South
n=243
% Resident in Local Authority where
service was based
34.8 47.8 53 13.6
% Resident in Strategic Health
Authority where service was based. 
56.6 75.2 72.3 34.7
At THT West in Bristol, 75.2% of testers lived in the local Strategic Health Authority
(Avon, Gloucestershire & Wiltshire) including 47.8% who lived in the City of Bristol,
(which includes Bristol South & West Primary Care Trust (PCT) where the service was
based and Bristol North PCT). The majority of other Bristol testers lived in adjoining areas
(10.6% in South Gloucestershire; 8.0% in Bath & North East Somerset; and 4.4% in
North Somerset). A further 8.0% stated their local authority of residence as Avon and
5.3% stated Somerset. Neither of these authorities exist any longer. 
At THT Yorkshire in Leeds, 72.3% of testers lived in the local Strategic Health Authority
(West Yorkshire) including 53.0% who lived in Leeds, (which includes the 5 Leeds PCTs);
6.3% in Bradford; 5.3% in Kirklees; 2.9% in Wakefield and 1.5% in Calderdale. Apart
from local authorities within the West Yorkshre SHA the most common answers were
Manchester (5.3%); Sheffield (3.4%); North Yorkshire (2.4%) and York (1.9%). 
Lighthouse South served a population dispersed over a much larger geographic area than
fasTest in Bristol or Leeds. Less than a third (31.8%) lived in the local SHA (South East
London) including only 13.6% in the PCT where the service was based (London Borough of
Lambeth) with another 11.1% from the adjoining Southwark and 3.3% from Lewisham.
More than half of users (56.6%) lived elsewhere in London, including 16.1% from North
Central London; 16.1% in North East London; 16.1% in North West London; and 8.3% in
South West London. One-in-nine (11.6%) testers at Lighthouse South lived outside
London. 
Area of residence by
gender and sexuality
(n=555, missing 38) 
All
Testers
n=558
All
Males
n=469
All
Females
n=89
Gay or Bi
Males
n=284
Hetero
Males
n=183
% Resident in Local Authority
where service was based
34.8 33 43.8 28.2 41
% Resident in Strategic
Health Authority where
service was based. 
56.6 55.3 62.9 53.4 59
While males seem less likely to be resident in the local PCT (33.0%) compared to females
(43.8%) this is a function of fasTest site and to some extent sexuality rather than gender.
Among heterosexuals, males (41.0%) and females (43.8%) do not differ in their likelihood
gsk fasTest evaluation, Sigma Research: 12 of  36
of living in the Local Authority where the service was based. However, Gay and Bisexual
men appeared significantly less likely to live in the area (28.2% did so). However there
were also substantial differences among Gay and Bisexual men by fasTest site. A much
higher proportion of testers lived in the Local Authority where the service was based in
Bristol (44.2%) and Leeds (43.5%) compared to Lighthouse South London (13.6%). 
Since more than half (52.1%) of Gay or Bisexual males testers were recruited in London
rather than Bristol or Leeds, the London/ not London site differences exacerbate the
differences around sexuality. 
There were no differences in residence at the Strategic Health Authority level by gender
and sexuality. 
3.1.7 Age
The mean age of the entire sample was 31.2 years (median 30). Overall, almost half
(45.9%) of all testers were under 30 years of age and more than a fifth (20.2%) were
under 25 years of age. Testers at the Leeds site were younger than in Bristol or
Lighthouse South London, irrespective of gender or sexuality. 
Age by fasTest site
(n=587, missing 6) 
% All
Testers
n=587
% THT
West
n=116
% THT
Yorkshire
n=218
% Lighthouse
South
n=253
Mean age 31.2 31.6 29.9 32.1
standard deviation 8 8.4 8.1 7.7
Median age 30 30 30 31
Range 17-68 18-58 17-68 19-60
Age GROUPS
15 - 19 years old 3.2 4.3 6 0.4
20 - 24 years old 17 14.7 23.4 12.6
25 - 29 years old 25.7 25.9 19.7 30.8
30 - 34 years old 26.2 23.3 31.2 23.3
35 - 39 years old 13.8 14.7 9.2 17.4
40 - 44 years old 7.3 6.9 6 8.7
45 or over 6.6 10.3 4.6 6.7
Females were significantly younger (mean 28.2, median 27) than males (mean 31.21,
median 31). This was true of the whole sample and for heterosexuals alone. 
Gay or Bisexual males (mean 31.9, median 31) were not significantly older than
heterosexual males (mean 31.5, median 31) on average. 
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Age by gender and sexuality 
(n=587, missing 6) 
All
Testers
n=587
All
Males
n=490
All
Females
n=97
Gay or Bi
Males
n=297
Hetero
Males
n=191
Mean age 31.2 31.7 28.2 31.9 31.5
standard dev. 8 8.1 6.4 8.8 7.1
Median age 30 31 27 31 31
Range 17-68 17-68 17-50 18-68 17-65
Age GROUPS
15 - 19 years 3.2 2.2 8.2 2.7 1.6
20 - 24 years 17 17.1 16.5 17.8 15.7
25 - 29 years 25.7 23.3 38.1 23.9 22
30 - 34 years 26.2 26.7 23.7 22.2 34
35 - 39 years 13.8 14.9 8.2 15.2 14.7
40 - 44 years 7.3 8.4 2.1 9.4 6.8
45 or over 6.6 7.3 3.1 8.8 5.2
3.1.8 Educational qualifications
All respondents were asked How many years of full-time education have you had since the
age of 16? They were asked to indicated one of the following: none, 1 or 2 years, 3 to 5
years, or 6 or more years. Overall, 10 people (1.7%) did not answer this question. The
following table shows overall responses and variation by fasTest site. 
One-in-ten (10.6%) of all testers had no full-time education beyond the age of sixteen
(suggesting O-levels/ GCSEs or less). A quarter (27.1%) had 2 years of education or less,
beyond the age of sixteen. 40.3% had 6 years or more, of education beyond the age of
sixteen, suggesting a university degree or more. 
Testers in Leeds were most likely to have no education beyond the age of 16 (15.1%) and
least likely to have six years or more. Testers in Lighthouse South were better educated
than those using Bristol. 
Years in full-time education since
the age of 16 by fasTest site
(n=583, missing 10)
% All
Testers
n=583
% THT
West
n=116
% THT
Yorkshire
n=218
% Lighthouse
South
n=249
None 10.6 10.3 15.1 6.8
1 or 2 years 16.5 19 19.7 12.4
3 to 5 years 32.6 31.9 33.5 32.1
6 or more years 40.3 38.8 31.7 48.6
These fasTest site effects were not a function of gender or sexuality. There were no
significant differences in education between male and female testers (42.9% of females
had 6 years of education or more compared to 39.8% of males). Similarly heterosexual
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males were not significantly better educated than Gay and Bisexual males (40.0% of
heterosexual males had 6 years of education or more compared to 40.0% of Gay or
Bisexual males). 
Years in full-time
education by gender and
sexuality 
(n=583, missing 10)
All
Testers
n=583
All
Males
n=487
All
Females
n=96
Gay or Bi
Males
n=295
Hetero
Males
n=190
None 10.6 11.7 5.2 9.8 14.7
1 or 2 years 16.5 15.8 19.8 17.8 13.2
3 to 5 years 32.6 32.6 32.3 32.5 32.1
6 or more years 40.3 39.8 42.7 40 40
However, among male testers there was a relationship between education and ethnicity.
White British males were least well educated (27.6% of White British males had 6 years of
education or more compared to 88.9% of Black African males and 70.0% of White other
males). Among female testers there was no relationship between ethnicity and educational
achievement.
3.2 PRIOR USE OF HIV & SEXUAL HEALTH SERVICES
3.2.1 Use of STI testing interventions
All respondents were asked When was the last time that you had a check-up for sexually
transmitted infections (other than HIV)? and offered the five answers outlined below.
Almost a third of all testers (30.7%, n=176) had never had a check-up for sexually
transmitted infections (STIs). Among respondents that have ever tested for STIs, testing
was relatively recent in the vast majority of cases. Overall just under half (43.3%, n=248)
had received a check-up for STIs in the last year. There was no significant difference in
STI screening history between testers at these three fasTest sites. 
Recency of STI check-up
by fasTest site
(n=573, missing 20)
% All
Testers
n=573
%
THT West
n=112
% THT
Yorkshire
n=213
% Lighthouse
South
n=248
In the last 6 months 26.9 23.2 28.2 27.4
6-12 months ago 16.4 13.4 14.1 19.8
1-5 years ago 20.4 21.4 17.4 22.6
five years ago or more 5.6 7.1 4.2 6
NEVER had a check-up 30.7 34.8 36.2 24.2
However, there were differences in STI screening histories by gender and sexuality. Gay or
Bisexual males and all females were significantly more likely to have been screened than
heterosexual males. Never having screened for STIs was most common among
heterosexual males (38.8%) and least common among Gay or Bisexual males (26.0%)
and females (28.4%). Having screened for STIs in the last year was most common among
females (49.5%) but substantially less common among heterosexual males (42.6%) and
Gay or Bisexual males (41.8%). 
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Recency of STI check-up
by gender and sexuality
(n=573, missing 20)
All
Testers
n=573
All
Males
n=478
All
Females
n=95
Gay or Bi
Males
n=289
Hetero
Males
n=188
In last 6 months 26.9 26.4 29.5 24.2 29.8
6-12 months ago 16.4 15.7 20 17.6 12.8
1-5 years ago 20.4 21.8 13.7 26.6 14.4
five years + 5.6 5 8.4 5.5 4.3
NEVER 30.7 31.2 28.4 26 38.8
There was no relationship between STI screening history and ethnicity overall, nor among
the heterosexuals alone. 
All those who had ever had an STI check-up were also asked Where was your last check-
up for sexually transmitted infections? They were offered four answers and an other
category. Respondents who ticked other were asked to say where the testing had occurred
and all were recoded to abroad, which included a variety of sites outside the UK (2.1%,
n=8) or to an NHS setting outside GUM or general practice (1.8%, n=7). 
Among those that had ever had an STI screen, 71.4% had their last one at a GUM clinic.
One-in-seven (13.0%) of those that had ever received a check-up for STIs had their last
one at a GP surgery; 6.3% had their last one at a private health care clinic; and 5.5%
cited a AIDS service organisation or a community setting. There were no significant
differences in response by fasTest site. 
Site of last check-up for STIs by
fasTest site
(respondents that had ever had a
STI check-up, n=384, missing 13)
% All
Testers
n=384
% THT
West
n=72
% THT
Yorkshire
n=130
% Lighthouse
South
n=182
GUM or sexual health clinic 71.4 73.6 75.4 67.6
GP surgery/ local doctor 13 13.9 14.6 11.5
Private health care clinic 6.3 2.8 4.6 8.8
AIDS Charity / community 5.5 6.9 3.1 6.6
ABROAD 2.1 1.4 1.5 2.7
NHS unspecified 1.8 1.4 0.8 2.7
However, there were differences in site of last STI screening by gender and sexuality.
Having used GUM for their last STI screen was most common among Gay or Bisexual men
(76.8% overall), and least common and females (57.4%). Conversely, females (29.5%)
were significantly more likely to have had their last STI screen in a GPs surgery compared
to either heterosexual males (12.5%) or Gay or Bisexual males (8.5%). This finding
occurred independent of ethnicity.
gsk fasTest evaluation, Sigma Research: 16 of  36
Site of last STI check-up by
gender and sexuality 
(respondents that had ever had a
STI check-up, n=384, missing 13)
All
Testers
n=384
All
Males
n=323
All
Females
n=61
Gay or Bi
Males
n=211
Hetero
Males
n=112
GUM or sexual health clinic 71.4 74 57.4 76.8 68.8
GP surgery 13 9.9 29.5 8.5 12.5
Private health care 6.3 6.2 6.6 7.1 4.5
AIDS Charity / community 5.5 5.9 3.3 4.3 8.9
ABROAD 2.1 2.2 1.6 1.4 3.6
NHS unspecified 1.8 1.9 1.6 1.9 1.8
3.2.2 HIV testing history
All respondents were asked Have you ever received an HIV test result before today? and
given the responses: No, I’ve never tested for HIV and received the result; yes, my last
test was HIV negative; and other. 
Two indicated that they had tested once previously but were awaiting the result, including
one who said “Went to GUM clinic to last week and was tested but told 3 weeks for results.
Panic attacks and depression caused me to come for new test and an immediate result”.
Two others stated that they were blood donors. Since the questions requires previously
receiving a test result all were recoded as never having tested. One tester ticked other
and indicated that they had previously tested positive for HIV. They were excluded from
this entire data set. 
Those who had tested negative were asked When was your most recent HIV test? (within
the last month; within the last three months; within the last year; in the last three years;
in the last five years; more than five years ago). The number of people indicating each
answer and the proportions they represent are shown below.
HIV testing history by
fasTest site 
(n=577, missing=16)
% All
Testers
n=577
% THT
West
n=114
% THT
Yorkshire
n=214
% Lighthouse
South
n=249
never tested 41.2 43 45.3 36.9
last
tested
negative
within last month 3.1 3.5 4.2 2
in the last 3 months 9.5 7.9 11.7 8.4
3-12 months ago 19.2 18.4 15.4 22.9
1-3 years ago 13.3 7 11.7 17.7
3-5 years ago 7.6 11.4 6.1 7.2
5+ years ago 5.2 7 5.1 4.4
Recency UNKNOWN 0.7 1.8 0.5 0.4
all negative tests 58.8 57 54.7 63.1
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41.2% of all respondents had never tested for HIV before. Among those that had ever
tested for HIV, more than half (31.8% of all) had tested negative in the previous year.
There were no significant differences in HIV testing history by fasTest site.
However, there were differences in HIV testing history by the sexuality of users. Having
tested negative previously was equally common among men (59.0%) and women
(57.4%) but substantially more common among Gay or Bisexual men (66.3%) compared
to heterosexual men (48.2%). Among heterosexuals, females were more likely to have
previously tested negative (57.4%) compared to heterosexual males (48.2%). 
HIV testing history by gender and
sexuality 
(n=577, missing=16)
All
Testers
n=577
All
Males
n=483
All
Females
n=94
Gay or Bi
Males
n=291
Hetero
Males
n=191
never tested 41.1 41 42.6 33.7 51.8
last
tested
negative
in last month 3.1 3.7 0 2.4 5.8
in last 3 months 9.5 9.7 8.5 7.2 13.6
3-12 months ago 19.3 19.9 16 23 15.2
1-3 years ago 13.4 13 14.9 18.2 5.2
3-5 years ago 7.6 7.9 6.4 9.6 5.2
5+ years ago 5.2 3.9 11.7 4.5 3.1
Recency unknown 0.7 0.8 0 1.4 0
all negative tests 58.9 59 57.4 66.3 48.2
Among fasTest users that had previously tested negative for HIV (58.9%), the average
number of previous negative tests was two. FasTest users in Lighthouse South were not
only most likely to have tested before (63.1% had) but among those that had tested
negative previously, they had tested more frequently (mean 3.08, median 2) compared to
users in Bristol (mean 2.39, median 2) and Leeds (mean number of previous negative
tests 1.91, median 1).
Number of negative tests
by fasTest site
(that had previously tested for
HIV, n=334, missing 5) 
% All
Testers
n=334
% THT
West
n=62
% THT
Yorkshire
n=115
% Lighthouse
South
n=157
Mean no. tests 2.55 2.39 1.91 3.08
standard deviation 2.55 1.77 1.51 3.22
Median no. tests 2 2 1 2
Range 38741 38990 38990 38741
These differences in frequency of testing were largely a function of gender and sexuality.
On average, men who had previously tested for HIV had done so more frequently than
women, and among men those who were Gay or Bisexual had tested more frequently than
heterosexuals. 
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Number of negative tests
by gender and sexuality
(that had previously tested for
HIV, n=334, missing 5)
All
Testers
n=334
All
Males
n=280
All
Females
n=54
Gay or Bi
Males
n=187
Hetero
Males
n=93
Mean no. tests 2.55 2.75 1.54 3.11 2.02
standard deviation 2.55 2.71 0.91 3.04 1.69
Median no. tests 2 2 1 2 1
Range 38741 38741 38837 38741 38990
The table below describes the reasons for never testing among those who had never done
so (41.1%). It is based on the question, Why have you never tested for HIV? Respondents
were offered the nine answers outlined and an other category. Those that ticked other
were asked to specify an other reason. 
By far the most common reason for not having previously tested was I have been too
afraid of the result being HIV positive (33.5%) of all respondents gave this answer. The
only other answers given by more than 10% of testers was I didn’t know where to go to
get tested” (at 14.8%) and I was afraid of discrimination if I tested HIV positive (11.2%). 
Reasons for NEVER having
HIV tested previously by
fasTest site (respondents that
had NEVER previously tested
for HIV, n=224, missing 13)
% All
Testers
n=224
% THT
West
n=44
% THT
Yorkshire
n=93
% Lighthouse
South
n=87
Been too afraid of the result
being HIV positive
33.5 34.1 34.4 32.2
Didn't know where to go to get
tested
14.8 15.9 14.1 14.9
Afraid of discrimination if I
test HIV positive
11.2 15.9 15.1 4.6
Afraid of discrimination if I test
(whatever the result)
9.4 13.6 9.7 6.9
Didn't know the test existed 5.8 2.3 10.8 2.3
Didn’t trust the places I knew I
could test
5.4 6.8 6.5 3.4
Not important for me to know
my HIV status
4.9 9.1 3.2 4.6
Would cause problems in my
relationship
3.6 4.5 3.2 3.4
People I know do not approve
of HIV testing
0.4 0 1.1 0
Other reasons, of which 
NO risk, No need
34.4 36.4 36.6 31
71.4 68.8 74.3 69.2
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A third (34.4%) of testers gave an other reason. The majority (71.4%) of these cited a
prior lack of risk as the main reason they had never tested. Most said “I have always had
safe sex”. The remainder either cited reasons associated with the prior relationship, long
waiting times or a fear of the process of testing. 
Only two of these answers were significantly varied by fasTest site. I was afraid of
discrimination if I tested HIV positive was far less common an answer in London (4.6%)
compared to Leeds (15.1%) and Bristol (15.1%). I didn't know the test existed was
significantly more common in Leeds (10.8%) than in Bristol (2.3%) or Lighthouse South
(2.3%). 
There was no variation in response by gender or ethnicity but there was by sexuality, for
two answers. The fasTest site variation described above in being I am afraid of
discrimination if I test positive was a function of sexual identity and fasTest site (as
reported above). The response was significantly more common among Gay men and
Bisexual men than heterosexual men, especially in Leeds (29.4% v 9.3%) and in Bristol
(21.4% v 11.1%) compared to London (6.5% v 0%). 
The only other significant difference by sexuality was that heterosexual males were
significantly more likely to say that they had not previously tested because they didn’t
know the test existed (8.9% of heterosexual males compared to 2.1% of Gay or Bisexual
men). 
Reasons for NEVER having HIV
tested by gender and sexuality
(respondents that had NEVER
previously tested for HIV, n=224,
missing 13)
All
Testers
n=224
All
Males
n=185
All
Females
n=39
Gay or Bi
Males
n=94
Hetero
Males
n=90
Been too afraid of the result being
HIV positive
33.5 32.4 38.5 36.2 28.9
Didn't know where to go to get
tested
14.8 13 23.1 13.8 12.4
Afraid of discrimination if I test
HIV positive
11.2 11.9 7.7 17 6.7
Afraid of discrimination if I test
(whatever the result)
9.4 10.3 5.1 13.8 6.7
Didn't know the test existed 5.8 5.4 7.7 2.1 8.9
Didn’t trust the places I knew I could
test
5.4 4.9 7.7 4.3 5.6
Not important for me to know my
HIV status
4.9 4.3 7.7 4.3 4.4
Would cause problems in my
relationship
3.6 3.8 2.6 4.3 3.3
People I know do not approve of HIV
testing
0.4 0 2.6 0 0
Other reasons, of which 
NO risk, No need
34.4 35.7 28.2 34 36.7
71.4 72.7 63.6 68.8 75.8
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3.2.3 Experience of HIV prevention interventions
All testers were asked, Before using this service, WHEN was the last time you saw
something or spoke to someone about HIV or safer sex? and offered the five answers
outlined in the table below (n=578, missing 15). 
One-in-six of all respondents (16.3%) had never seen something or spoken to someone
about safer sex. Among respondents that had ever seen something or spoken to someone
about safer sex, this had occurred relatively recently in the majority of cases. Overall just
under two-thirds of all respondents (63.3%) had seen something or spoken to someone
about safer sex in the last year (48.6% in the last 6 months and 14.7%, 7-12 months
ago).
Last time you saw something or
spoke to someone about HIV or
safer sex by fasTest site
(n=578, missing 15)
% All
Testers
n=578
% THT
West
n=113
% THT
Yorkshire
n=216
% Lighthouse
South
n=249
In the last six months 48.6 48.7 48.1 49
In the last year 14.7 12.4 13.4 16.9
In the last five years 14 14.2 13.9 14.1
More than five years ago 6.4 8 6.5 5.6
NEVER 16.3 16.8 18.1 14.5
The were no significant differences across fasTest sites in whether testers had ever seen
something or spoken to someone about safer sex, or how recently they had done so. 
Last time you saw something or
spoke to someone about HIV or
safer sex by gender and
sexuality (n=578, missing 15)
All
Testers
n=578
All
Males
n=483
All
Females
n=95
Gay or Bi
Males
n=292
Hetero
Males
n=190
In the last six months 48.8 47.2 55.8 47.3 47.4
In the last year 14.7 14.9 13.7 16.1 13.2
In the last five years 14 14.9 9.5 19.9 7.4
More than five years ago 6.4 6 8.4 4.5 8.4
NEVER 16.3 17 12.6 12.3 23.7
Having seen something or spoken to someone about safer sex in the last year was most
common among heterosexual females (69.5%) but less common among Gay or Bisexual
males (63.4%) and heterosexual males (60.6%). Among heterosexuals there was a
significant difference by gender in whether testers had ever seen anything or spoken to
someone about HIV or safer sex: 23.7% of heterosexual males had never done so
compared to 13.5% of heterosexual females. Experience of HIV prevention interventions
did not vary by ethnicity if we controlled for gender and sexuality.
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3.3 SEXUAL BEHAVIOUR
All fasTest users were asked the same eight questions about sex with men and women, 
irrespective of their gender and sexuality. The eight questions represented two identical
sets of four - one concerning sex with men and the other concerning sex with women. 
The first question in each set of four concerned partner numbers in the last twelve
months. It read: In total how many MEN (or WOMEN) have you had sexual contact with in
the last 12 months? For both these questions the respondent could chose one of the same
fifteen answers ranging from none to 30 or more. This wide range of potential responses
was used to ensure comparability with a variety of pre-existing data sets. 
In each set of four, this question was followed with three concerning recency of having a
new (male or female) partner; recency of having “intercourse” (with a man or woman)
without a condom; and recency of having sex (with a man or woman) you knew at the
time had HIV? For all three of these questions the respondent could chose one of the same
six answers: Within the last week; Within the last three months; Within the last year;
Within the last five years; More than five years ago; and Never had sex with a man
Overall, 4-5% of respondents failed to answer each of the questions above, including just
over 2% who answered none of the eight sexual behaviour questions. These questions had
the highest proportion of missing data in the questionnaire. 
In all the sexual behaviour data that follows fasTest site has little or no predictive value
beyond the gender, sexuality and ethnicity of fasTest users. Where any site differences
exist they are noted in the text. 
3.3.1 Recency of having a NEW sexual partner
As we might expect there was some flexibility between sexual identity and sexual
behaviour. Among heterosexuals 6.7% of males had ever had sex with a male and 5% of
females had ever had sex with a female. The sample also contains some young people
very early in their sexual career: 1% of heterosexual males had not yet had sex with a
female and 1% of heterosexual females had not yet had sex with a male. A smaller
proportion (0.4%) of Gay or Bisexual males had not yet had sex with a male. 
In this data on recency of new sexual partnerships, sexuality is more important than
gender, in that male and female heterosexuals have very similar rates, as do Gay, Lesbian
and Bisexual males and females, with the latter having new partners significantly more
recently. 
Among heterosexuals, 6.1% of males had a new female partner in the last week compared
to 7.9% of females having a new male partner. Similarly, 46.4% of males had a new
female partner in the last 3 months compared to 38.2% of females having a new male
partner. Finally, 77.3% of males had a new female partner in the last year compared to
69.7% of females having a new male partner. 
Homosexually active males and females had new partners significantly more recently than
heterosexuals. A fifth (20.4%) of Gay or Bisexual males have had a new male partner in
the last week and almost two thirds (64.1%) have had a new male partner in the last
three months. In addition, 11.5% of Gay or Bisexual males had a new female partner in
the last year.
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How long since you had a NEW
MALE partner by gender and
sexuality (n=568, missing 25)
All
Testers
n=568
All
Males
n=479
All
Females
n=89
Gay or Bi
Males
n=284
Hetero
Males
n=219
Within the last week 11.6 12.3 7.9 20.4 0.5
Within the last 3 months 28 27.6 30.3 43.7 4.1
Within the last year 16.2 13.4 31.5 22.2 0.5
Within the last 5 years 7.6 5 21.3 8.1 0.5
More than five 5 years ago 4 3.5 6.7 5.3 1
Never had sex with a man 32.6 38.2 2.2 0.4 93.3
How long since you had a NEW
FEMALE partner by gender and
sexuality (n=572, missing 21)
All
Testers
n=572
All
Males
n=477
All
Females
n=95
Gay or Bi
Males
n=296
Hetero
Males
n=181
Within the last week 1.9 2.3 0 0 6.1
Within the last 3 months 15.4 18 2.1 4.4 40.3
Within the last year 13.6 16.1 1.1 7.1 30.9
Within the last 5 years 8.2 9.2 3.2 6.1 14.4
More than five 5 years ago 9.1 10.9 0 13.2 7.2
Never had sex with a woman 51.8 43.4 93.7 69.2 1.1
3.3.2 Recency of having unprotected intercourse 
The following data considers recency of having intercourse without a condom. It does not
consider whether that partner was ‘new’ and will include some people having unprotected
intercourse (UI) in long-term monogamous relationships. 
Again, in this data sexuality is more important than gender, in that male and female
heterosexuals have very similar rates, which are different from Gay and Bisexual males. 
This time, Gay and Bisexual men are MORE likely to report never having had UI and to
report having done so significantly LESS recently. However, one-in-seven (13.3%) Gay or
Bisexual men had UI with a male partner in the last week; 38.9% in the last three
months; and 65.9% in the last year. In addition 9.5% of Gay or Bisexual males had UI
with a female partner in the last year. 
Among heterosexuals, 12.7% of males had unprotected intercourse (UI) with a female
partner in the last week compared to 22.2% of females having UI with a male partner.
Similarly, half (49.7%) of males had UI with a female partner in the last 3 months
compared to 52.2% of females having UI with a male partner. Finally, 80.6% of males
had a UI with a female partner in the last year compared to 85.5% of females having UI
with a male partner. In addition, in the last year, 4.1% of heterosexual males had UI with
a male partner and 2% of heterosexual females had UI with a female partner. 
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How long since you had
INTERCOURSE with a MAN
without a condom by gender and
sexuality (n=568, missing 25)
All
Testers
n=568
All
Males
n=479
All
Females
n=90
Gay or Bi
Males
n=285
Hetero
Males
n=194
Within the last week 10.4 8.1 22.2 13.3 0.5
Within the last 3 months 18.6 16.5 30 25.6 3.1
Within the last year 17.4 16.3 23.3 27 0.5
Within the last 5 years 7.6 6.5 13.3 10.2 1
More than five 5 years ago 3.9 4 3.3 6 1
Never had intercourse with a man
without a condom
42.1 48.6 7.8 17.9 93.8
How long since you had
INTERCOURSE with a WOMAN
without a condom by gender and
sexuality  (n=569, missing 24)
All
Testers
n=569
All
Males
n=477
All
Females
n=92
Gay or Bi
Males
n=296
Hetero
Males
n=181
Within the last week 4.2 4.8 1.1 0 12.7
Within the last 3 months 13.2 15.5 1.1 2.4 37
Within the last year 13.5 16.1 0 7.1 30.9
Within the last 5 years 4.6 5.2 1.1 3.7 7.7
More than five 5 years ago 5.8 6.9 0 9.1 3.3
Never had intercourse with a woman
without a condom
58.7 51.4 96.8 77.7 8.3
3.3.3 Recency of having sex with a known HIV sero-discordant partner
The following data considers recency of having any kind of sex with a partner who was
known to have HIV. It does not consider whether that partner was new or what kind of sex
occurred with them and will include some people having safer sex in long-term
relationships they know to be HIV sero-discordant. 
Again, in this data sexuality is more important than gender, in that male and female
heterosexuals have broadly similar rates, which are significantly different from those
reported by Gay and Bisexual males. This time, Gay and Bisexual men are LESS likely to
report never having had sex with a person known to have HIV and report having done so
significantly MORE recently. 
One-in-eight (12.4%) Gay or Bisexual males had sex with a male partner known to have
HIV in the last three months and almost a fifth (19.5%) had done so in the last year.
Among heterosexuals, 2.9% of males had sex with a female partner known to have HIV in
the last three months compared to 3.3% of females having sex with a male partner known
to have HIV.
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How long since any kind of sex
with a MAN you KNEW AT THE
TIME HAD HIV by gender and
sexuality (n=566, missing 27)
All
Testers
n=566
All
Males
n=477
All
Females
n=89
Gay or Bi
Males
n=283
Hetero
Males
n=194
Within the last week 3 3.1 2.2 5.3 0
Within the last 3 months 3.7 4.2 1.1 7.1 0
Within the last year 3.5 4.2 0 7.1 0
Within the last 5 years 2.3 2.7 0 4.6 0
More than 5 years ago 2.8 3.1 1.1 5.3 0
Never had sex with a man I knew
had HIV
84.6 82.6 95.5 70.7 100
How long since any kind of sex
with a WOMAN you KNEW HAD
HIV by gender and sexuality 
(n=566, missing 27)
All
Testers
n=566
All
Males
n=471
All
Females
n=95
Gay or Bi
Males
n=295
Hetero
Males
n=176
Within the last week 0.2 0.2 0 0 0.6
Within the last 3 months 0.9 1.1 0 0.3 2.3
Within the last year 0.2 0.2 0 0.3 0
Within the last 5 years 0 0 0 0 0
More than five 5 years ago 0.4 0.4 0 0.7 0
Never had sex with a woman I knew
had HIV
98.4 98.1 100 98.7 97.2
3.3.4 Volume of sexual partners in the last year
As we reported above there is some flexibility between sexual identity and sexual
behaviour. Among heterosexual males, 5.4% had sex with a male in the last year,
although the majority only had one male partner. Similarly 5% of heterosexual females
had sex with a female, although again most did so with one partner. 
The sample also contains some people were are not currently sexually active. One-in-
twenty (5%) female heterosexuals had no male partners in the last year and 2.7% of
heterosexual males had no female partners. Somewhat fewer (2.1%) Gay or Bisexual
males had no male partners in the last year. 
In this data both gender and sexuality are important. Overall, males report higher partner
numbers than females, and this effect is exacerbated by the particularly high numbers of
male partners reported by Gay and Bisexual men. 
Considering only partners of the opposite gender, heterosexual females were more likely
to report one (39.1%) partner in the last year, compared to heterosexual males (32.6%).
Conversely heterosexual males were significantly more likely to report 4 or more partners
of the opposite gender compared to heterosexual females (21.2% of heterosexual males
compared to 11.9% of heterosexual females). 
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Gay and Bisexual report significantly more partners than heterosexuals. Considering only
male partners they were least likely to report none (2.1%); one (15.6%) or two (9.4%)
partners in the last year. Almost two thirds (60.4%) of Gay or Bisexual men report 4 or
more male partners, compared to 21.2% of heterosexual males reporting 4 or more
female partners and 11.9% of heterosexual females reporting 4 or more male partners. 
Among Gay and Bisexual men 6.6% report 30 or more male partners in the last year;
18.4% report 13 or more male partners; and 49.3% report 5 or more male partners.
Compared to samples of Gay and Bisexual men recruited to the Gay Men’s Sex Survey
those using fasTest have significantly higher male partner numbers after you control HIV
testing history and area of residence. 
Volume of MALE sexual partners
in the last year by gender and
sexuality (n=566, missing 27)
All
Testers
n=566
All
Males
n=474
All
Females
n=92
Gay or Bi
Males
n=288
Hetero
Males
n=186
None 33.4 38.4 7.6 2.1 94.6
1 15.5 11 39.1 15.6 3.8
2 9.5 6.1 27.2 9.4 1.1
3 8.7 7.6 14.1 12.5 0
4 6.7 7 5.4 11.1 0.5
5 - 12 16.6 18.8 5.4 30.9 0
13 - 29 6 7.2 0 11.8 0
30 + 3.5 4 1.1 6.6 0
Volume of FEMALE sexual
partners in the last year by
gender and sexuality 
(n=567, missing 26)
All
Testers
n=567
All
Males
n=474
All
Females
n=93
Gay or Bi
Males
n=290
Hetero
Males
n=184
None 59.8 53.2 93.5 85.2 2.7
1 15 17.1 4.3 7.2 32.6
2 12.5 15 0 4.5 31.5
3 4.4 5.1 1.1 0.7 12
4 3.2 3.6 1.1 1 7.6
5 - 12 4.6 5.5 0 1.4 12
13 - 29 0.5 0.6 0 0 1.6
30 + 0 0 0 0 0
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3.4 USING FASTEST 
3.4.1 HIV prevalence in fasTest
In total 593 people tested for HIV in the gsk funded fasTest pilot sites and completed our
evaluation questionnaire. Among these 17 received a new HIV positive diagnosis at an
overall HIV prevalence of 2.9%. Of these 17 positives, 15 received a confirmatory HIV
positive diagnosis on serology (2 of 2 in Bristol; 5 of 6 in Leeds; and 8 of 9 in Lighthouse
South London). For follow-on blood results and proportions of positives known to be
entering care from the overall monitoring data see section 2.5. 
Abbott Determine test
results by fasTest site
 (n=593, missing 0) 
% All
Testers
n=593
%
THT West
n=117
% THT
Yorkshire
n=222
% Lighthouse
South
n=254
ALL fasTest POSITIVES 2.9%
17/593
1.7%
2/117
2.7%
6/222
3.5%
9/254
HIV prevalence varied by gender, sexuality and ethnicity. Compared to heterosexuals, Gay
and Bisexual men had a higher overall HIV prevalence (4.3%, 13/299). This varied by
fasTest site with a prevalence among Gay and Bisexual men of 3.2% (3 of 93) in Leeds;
3.8% (2 of 53) in Bristol; and 5.2% (8 of 153) in Lighthouse South London. 
Prevalence also varied by ethnicity among Gay and Bisexual men: 3.9% (8/203) of White
British men tested positive compared to 5.5% (3/55) of White other men. While the
sample size was very small, Black African (17%, 1/6) Gay and Bisexual men had the
highest HIV prevalence of all the sub-groups reported below. One other Gay man of South
East Asian ethnicity also tested positive for HIV in fasTest. 
% positive on Abbott Determine by
ethnicity, gender and sexuality
All
Testers
n=593
All
Males
n=496
All
Females
n=97
Gay or Bi
Males
n=299
Hetero
Males
n=195
All fasTest positives 2.9%
17/593
3.0%
15/496
2%
2/97
4.3%
13/299
1.0%
2/195
positives: White British (n=382) 2.1%
8/382
2.4%
8/333
0%
0/49
3.9%
8/203
0%
0/129
positives: White Other (n=101) 3%
3/101
4%
3/80
0%
0/21
6%
3/55
0%
0/24
positives: Black African (n=36) 8%
3/36
9%
2/22
7%
1/14
17%
1/6
6%
1/16
positives: Black Caribbean (n=13) 8%
1/13
10%
1/10
0%
0/3
0%
0/6
25%
1/4
positives: all other ethnic groups
(n=60)
3%
2/60
2%
1/50
10%
1/10
3%
1/29
0%
0/21
Among heterosexuals using fasTest a HIV prevalence of 1.0% was observed for males
(2/195) and 2.2% for females (2/91), giving an overall rate of 1.4% (4/286). Prevalence
varied by fasTest site for both male and female heterosexuals. In Bristol none of the 63
heterosexuals testing were diagnosed positive, compared to 1.0% (1/100) in Lighthouse
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South and 2.4% (3/123) in Leeds. 
Prevalence also varied by ethnicity among heterosexuals. The two heterosexual males
testing positive were Black African and Black Caribbean respectively. The two female
heterosexuals testing positive were Black African and mixed ethnicity: white and Black
African respectively. None of the 178 White British heterosexuals tested at these three
sites had undiagnosed HIV
3.4.2 Expectation of fasTest result
Prior to taking their fasTest all testers were asked What are you expecting the HIV test result
to be today? and offered the five answers outlined in the table below. 
Overall one third (31.7%) felt the were almost certainly negative and a further third
(31.0%) felt they were probably negative. The majority of the remainder (30.6%) said
they couldn’t say, with just 5.2% answering probably positive and 1.6% saying almost
certainly positive. There were no significant differences in expectation of a positive result
by fasTest site. 
Expectation of HIV test
result by fasTest site
(n=562, missing 31)
% All
Testers
n=562
% THT
West
n=112
% THT
Yorkshire
n=212
% Lighthouse
South
n=238
Almost certainly negative 31.7 26.8 33.5 32.4
Probably negative 31 32.1 28.8 32.4
Couldn’t say 30.6 32.1 33 27.7
Probably positive 5.2 7.1 4.2 5
Almost certainly positive 1.6 1.8 0.5 2.5
There were no significant differences in expectation of fasTest results by gender or
sexuality of users. Among heterosexuals, expectations of test outcomes were broadly
similar across gender,  with 6.1% of men expecting a positive result compared to 5.7% of
women. There was no relationship between ethnicity and expected test outcomes among
heterosexuals or Gay or Bisexual men. Of the  6 Lesbian or Bisexual women using these
fasTest sites none expected a positive result (and none received one).
Expectation of HIV test result by
gender and sexuality 
(n=562, missing 31)
All
Testers
n=562
All
Males
n=469
All
Females
n=93
Gay or Bi
Males
n=287
Hetero
Males
n=181
Almost certainly negative 31.7 30.7 36.6 28.6 34.3
Probably negative 31 30.5 33.3 33.4 25.4
Couldn’t say 30.6 31.8 24.7 30.3 34.3
Probably positive 5.2 5.3 4.3 6.3 3.9
Almost certainly positive 1.6 1.7 1.1 1.4 2.2
POSITIVE on fasTest 2.9 3 2 4.3 1
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3.4.3 Expectation of fasTest result by actual result
Of the 286 heterosexual men and women testing for HIV, four were positive (1.4%
prevalence overall). One heterosexual woman who received a positive result did not
answer the question on her expectations of the test result. Only one of the other three
heterosexuals with undiagnosed HIV predicted being positive prior to the fasTest. 
HETEROSEXUAL RESPONDENTS ONLY. 
HIV test result by expectation of HIV test
result (n=268, missing 18)
fasTest
Negative
(%, n)
fasTest
Positive
(%, n)
Almost certainly negative (n=94) 99 (93) 1 (1)
Probably negative (n=74) 100 (74) 0 (0)
Couldn’t say (n=84) 99 (83) 1 (1)
Probably positive (n=11) 91 (10) 9 (1)
Almost certainly positive (n=5) 100 (5) 0 (0)
Total (n=268) 98.9 (265) 1.1 (3)
Of 91 heterosexual women tested, 4 reported they were probably positive and 1 said she
was almost certainly positive. Only one of these five was positive. A similar pattern was
observed with the heterosexual males. Of the 181 heterosexual men tested and answering
the question on expectations, seven answered they were probably and 4 answered they
were almost certainly positive. None of these eleven heterosexual men tested positive. Of
the two heterosexual men testing positive one had predicted he was almost certainly
negative and one couldn’t say.
Of the 299 Gay or Bisexual men testing for HIV, thirteen were positive (4.3% prevalence).
Of these men undiagnosed HIV, ten answered the question on their expectation of the test
outcome. Less than half predicted being positive before the fasTest was administered. 
GAY OR BISEXUAL MEN ONLY. 
HIV test result by expectation of HIV test
result (n=287, missing 12) 
fasTest
Negative
(%, n)
fasTest
Positive
(%, n)
Almost certainly negative (n=82) 100 (82) 0 (0)
Probably negative (n=96) 98 (94) 2 (2)
Couldn’t say (n=87) 95 (83) 5 (4)
Probably positive (n=18) 94 (17) 6 (1)
Almost certainly positive (n=4) 25 (1) 75 (3)
Total (n=287) 96.5 (277) 3.5 (10)
Of the 287 Gay or Bisexual men stating their expectations of the fasTest, 18 replied
probably positive and only one (or 6%) of these received a positive fasTest result. A
further four had answered almost certainly positive and three (or 75%) of these received a
positive fasTest result. All the Gay or Bisexual men (n=82) who stated they were almost
certainly negative were correct. However, two men received a positive fasTest result after
stating they were probably negative and four (or 5%) of the 87 Gay or Bisexual men who
answered couldn’t say to the expectation question received a positive fasTest result. 
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3.4.4 Potential source of HIV infection
All testers were asked If today’s test for HIV is positive, how do you think you may have
got HIV? and offered the five answers outlined below and an other option. Those that
ticked other were asked to specify how else they might have been infected. Respondents
were allowed to tick as many answers as applied but 97.0% ticked only one. 
The majority (62.7%) of all testers felt that if they were positive they had been infected
during sex with a man. This answer was significantly more common in Bristol (66.7%) and
Lighthouse South (67.6%) and less common in Leeds (55.0%). Overall, one quarter
(27.4%) felt they might have been infected during sex with a woman. One-in-twelve
(8.1%) answered that they did not know or had no idea how they might have been
infected and this was most common among users of Leeds (2.9%). 
If HIV positive, how did
you get HIV by fasTest
site (n=558, missing 35)
% All
Testers
n=558
% THT
West
n=111
% THT
Yorkshire
n=209
% Lighthouse
South
n=238
During sex with a man 62.7 66.7 55 67.6
During sex with a woman 27.4 27.9 30.6 24.4
Don’t know / no idea 8.1 4.5 8.6 9.2
From medical procedures 1.3 0 2.9 0.4
Sharing injecting equipment 0.5 0 1.4 0
Other 2.9 3.6 3.3 2.1
Less than 1% of all testers felt they could have been infected through injecting drug use
and 1.3% through medical procedures. The 10 other answers specified were oral sex (2),
bite (1), possible assault (1), via contact with a positive care worker (1); through work
(1); via blood (1); via a cut on finger (1); tattoos (1) and sharing accommodation (1). 
The majority (62.7%) of all testers felt that if they were positive they had been infected
during sex with a man. This was the most common response from Gay and Bisexual men
(89.8%) and from women (88.0%). The most common answer from heterosexual men
was during sex with a woman (79.4%). None of the other answers varied by gender or
sexuality.
If HIV positive, how did you get
HIV by gender and sexuality
(n=558, missing 35)
All
Testers
n=558
All
Males
n=466
All
Females
n=92
Gay or Bi
Males
n=285
Hetero
Males
n=180
sex with a man 62.7 57.7 88 89.8 7.2
sex with a woman 27.4 32.6 1.1 2.8 79.4
Don’t know / no idea 8.1 8.2 7.6 7 10
from medical procedures 1.3 1.1 2.2 0.4 2.2
sharing injecting equipment 0.5 0.4 1.1 0 1.1
Other 2.9 3 2.2 2.5 3.9
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Compared to White British (4.3%) and White other (9.5%) ethnic groups, Black African
(22.2%) heterosexuals were significantly more likely to report no idea what the source of
their potential infection might be. None of the other answers varied by the ethnicity of
testers. 
3.4.5 Reasons for choosing fasTest
All testers were asked Why have you chosen to take the test here rather than somewhere
else? and offered the seven answers outlined below, and an other option. Those that
ticked other were asked to specify how else they might have been infected. Respondents
were allowed to tick as many answers as applied but only a quarter (23%) ticked more
than one. Two of these responses varied significantly by fasTest site used (marked in bold
in the table). 
More than half (50.2%) of all respondents reported that their main reason for choosing
fasTest over other options for HIV testing was because the test result is available at the
same visit.
Reasons for choosing fasTest over
other options, by site attended
(n=566, missing 27)
% All
Testers
n=566
% THT
West
n=113
% THT
Yorkshire
n=213
% Lighthouse
South
n=240
Because the test result is available at the
same visit at this clinic
50.2 52.2 45.1 53.8
It is more convenient to come here 32.7 32.7 27.7 37.1
I had difficulty getting an
appointment at the sexual health
clinic (GUM clinic)
20.8 23 26.3 15
I don’t know anywhere else to test 10.8 15.9 9.4 9.6
I don't like going to the sexual health
clinic (GUM clinic) 
10.3 10.7 12.7 7.9
Because friends recommended it 10.2 9.7 14.6 6.7
Because this test uses a finger-prick test
rather than a traditional blood test
8 8 7 8.8
Other reason 11.8 13.3 11.3 11.7
Another third (32.7%) of all respondents stated that it is more convenient to come here.
This answer was assumed to refer to both the ‘after hours’ nature of the service and the
absence of any need for an appointment. It could also include the physical setting of the
intervention (ie. not out-patients in a hospital or primary care) though this was rarely
mentioned in other comments (see below). This response was significantly more common
among those that had tested before (37.6%) compared to those that had not (26.3%). 
Some testers revealed they had chosen fasTest for more problematic reasons: a fifth
(20.8%) reported they had difficulty getting an appointment in GUM. This reason for using
fasTest was significantly more common in Leeds (26.3%) and Bristol (23.0%) than in
London (15.0%). It was also was significantly more common among those that had tested
before (24.5%) compared to those that had not (15.9%). Another 10.3% stated that they
did not like going to GUM. 
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Also of concern was that 10.8% did not know where else to test for HIV. Not surprisingly,
this response was significantly more common among those that had never tested before
(15.5%) compared to those that had (7.3%) previously tested negative.
Personal recommendation was important to 10.2% of fasTest users. This reason for using
fasTest was most common in Leeds (14.6%) and least common in London (6.7%). 
The use of finger-prick rather than full serology was only important to 8.0% of all users. 
This response was significantly more common among those that had tested before
(10.1%) compared to those that had not (5.2%). 
The two main reasons outlined above were reiterated in more than half of the other
answers. These concerned the speed of the service including the availability of the result
on that day - or within one hour - as the most important reason for attendance. Some of
these answers also commended the easy accessibility of the service and the relatively
short waiting times. This confirms the fasTest service was valued for its speed and its
accessibility. Of the remaining other answers some complained about local GUM services
including long waiting times and no availability of same day testing outside office hours.
Relatively few testers specifically commended THT or suggested they had chosen the
service because of its community setting. 
Reasons for choosing fasTest over
other options, by gender and
sexuality (n=566, missing 27)
All
Testers
n=566
All
Males
n=473
All
Females
n=93
Gay or Bi
Males
n=289
Hetero
Males
n=183
Because the test result is available
at the same visit 
50.2 48.4 59.1 52.2 42.1
More convenient to come here 32.7 34 25.8 32.2 36.6
Difficulty getting an appointment at the
sexual health clinic (GUM clinic)
20.8 21.8 16.1 23.5 18.6
I don’t know anywhere else to test 10.8 10.1 14 8 13.7
I don't like going to the sexual health
clinic (GUM clinic) 
10.3 10.2 10.8 10.1 10.4
Because friends recommended it 10.2 9.5 14 10 8.7
Because this test uses a finger-prick test
rather than a traditional blood test
8 8.5 5.4 9.7 6.6
Other reason 11.8 11.4 14 12.1 10.4
Just one of the reasons for choosing fasTest varied by gender and sexuality. Heterosexual
females were more likely to chose fasTest because the test result is available at the same
visit (58.6% compared to 42.1% of heterosexual males). Once sexuality and gender were
controlled for there was no variation in any of the reasons for choosing fasTest over other
options for HIV testing by ethnicity. 
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3.4.6 First hearing of the fasTest service
In all three sites specific fasTest leaflets were available alongside posters advertising the
service. Some outreach activity also promoted all the fasTest sites (see THT process report
for full description of the promotional activity and the cost breakdown). 
All testers were asked How did you first hear about this HIV testing service? and offered
the eight answers outlined below. While all respondents were allowed to give more than
one answer, only 4% did so. Among all testers there was significant variation in how they
first discovered fasTest by the THT site of service, their gender, sexual identity and
ethnicity. The two tables below outline variation by fasTest site, and then by gender and
sexual identity. 
Only two of the eight means of first hearing about the fasTest service significantly varied
by fasTest site (these are in bold). Having first heard about the service online was most
common in Lighthouse South and least common in Leeds. Having heard about the service
from a worker was most common in Bristol and least common in Lighthouse South. The
specific promotional activities undertaken in each site are currently insufficiently well
described to make any further comment on site differences. It is worth noting, however,
that no single site should expect to recruit the highest proportion of users from every
promotional activity. There was usually only one way each user first heard of the service,
and having given that answer they usually did not give any other. 
How did you first hear about
fasTest by site attended
(n=565, missing 28) 
% All
Testers
n=565
% THT
West
n=113
% THT
Yorkshire
n=212
% Lighthouse
South
n=240
The internet 53.5 50.4 42.9 64.2
A friend told me about it 20 23.9 23.1 15.4
A leaflet or information card 8.7 10.6 10.8 5.8
From a helpline 5.8 2.7 6.1 7.1
A worker approached me 4.1 7.1 5.7 1.3
A poster 3.7 0.9 4.7 4.2
Advert in the press 3.5 2.7 5.2 2.5
I was there for something else 0.5 1.8 0 0.4
Testers means of first hearing about the intervention did not vary by gender or sexuality.
Among both genders and irrespective of sexual identity or practice, the most common
answer for first hearing about the service was via the internet. Of the 53.5% of all testers
that specified the internet as the site of first hearing about the intervention, 16.9% did
not specify which website they had used. Of the remainder almost two thirds (64.8%)
cited www.tht.org.uk as the source of their knowledge about it. As one of few websites
that specified where and when the service occurred this was not surprising. Another
website specifically promoting HIV testing and targeting Gay men
(www.youchoose.org.uk) also described some fasTest sites and this was cited by 4.3% of
all respondents (actually 8.3% of Gay and Bisexual men and one heterosexual females). A
further quarter (22.6%) of all testers specified an internet search engine, usually Google
(20.3%). A small number (3.9%) of all respondents cited advertising on
www.gaydar.co.uk though this represents 8.3% of Gay and Bisexual men citing the
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internet, and none of the heterosexuals. 
How did you first hear about
fasTest by gender and sexuality
(n=565, missing 28) 
All
Testers
n=565
All
Males
n=472
All
Females
n=93
Gay or Bi
Males
n=288
Hetero
Males
n=183
The internet 53.5 53.8 51.6 50 59.6
A friend told me about it 20 20.1 19.4 21.5 18
A leaflet or information card 8.7 8.1 11.8 8 8.2
From a helpline 5.8 6.1 4.3 6.9 4.9
A worker approached me 4.1 4 4.3 3.8 4.4
A poster 3.7 3.2 6.5 3.8 2.2
Advert in the press 3.5 3.6 3.2 4.9 1.6
I there for something else 0.5 0.6 0 0.7 0.5
Personal recommendation from friends was the next most common means of first hearing
about the service. No other source of recruits to fasTest accounted for more than 10% of
all attenders. 
The key written means of advertising the individual fasTest clinics were the THT fasTest
(blue) leaflet and smaller (A8) information card - cited by 8.7% of all testers - and
accompanying THT fasTest posters - mentioned by 3.7% of testers. People who saw
leaflets or information cards did so at a range of settings including collaborating (and
other) GUM services and a few other NHS settings (including a few GP surgeries) or via
distribution in Gay bars. People who saw posters did so at a range of settings including
collaborating (and other) GUM services and a few Gay bars. Adverts in the press were
cited by only 3.5% of testers as a means of first hearing about the service. Shout
magazine (a Gay title based in Leeds) accounted for more than half of these mentions. 
Direct ‘referrals’ from telephone helplines and workers were also mentioned by 5.8% and
4.1% of respondents respectively. Half of the helpline referrals came from THT Direct, but
worker referrals came form a wide variety of professional sources including sexual health
clinics and AIDS service organisations and other NHS and voluntary sector generic
services. 
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4. Experiences of people diagnosed with HIV in fasTest
One final element of our evaluation involved asking all fasTest users to consent to a
follow-up telephone interview if they tested POSITIVE on fasTest. This signed consent was
recorded on the patient registration form to maintain the anonymity of the evaluation for
all users that tested negative and to offer all testers the opportunity to maintain their
anonymity irrespective of their fasTest result. 
We relied on clinical staff administering fasTest to give us the referrals and contact details
of all those that consented to follow-up. In most cases this was only done after the new
positive had returned to the host GUM for follow-up bloods and initial care and support. In
most instances their written consent to follow-up prior to taking the fasTest was verbally
confirmed prior to a referral to Sigma. 
Referrals for follow-up interview usually occurred 6-12 weeks after initial diagnosis. Some
came with a proviso that the interview should be left up to another 6 -12 weeks. The table
below describes the number of new positives consenting, and the numbers contacted who
subsequently refused to be interviewed, were interview, or asked us to call back at a later
date. 
Consent to telephone interviews
among new positives 
Total THT
West
THT
Yorkshire
Lighthouse
South
Total of VALID positives 20 4 7 9
Consented to telephone interview 9 1 2 6
REFUSALS after initial consent 0 0 0 0
Telephone interviews completed 7 1 2 4
Telephone interviews outstanding 2 0 0 2
Of the 20 new positives in the three sites only 9 consented to follow-up interview. On
contact 2 asked us to call again in “a couple of months”. Both these calls are due at the
end of March 2006. To date 7 interviews have been completed, lasting 20-30 minutes
each. In view of the limited number of new positives in the 3 sites, and the relatively low
rates of consent to follow-up (especially in Bristol and Leeds) we propose to try and
complete the last two interviews prior to reporting. 
Interim analysis of the first 7 completed interviews suggest that overall satisfaction with
the fasTest service is exceptionally high, as is satisfaction with referral pathways into
standard HIV care. 
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5. EVALUATION SUMMARY 
5.1 FEASIBILITY 
It is feasible to establish and administer fasTest HIV testing interventions in community
settings (ie outside GUM out-patients). In the pilot they were established as satellite GUM
HIV testing services with clinical governance provided by the host GUM service. They can
be challenging partnerships to establish and maintain. 
5.2 AFFORDABILITY
The unit costs of the intervention has proved difficult to establish. We estimate in the
entire fasTest pilot each HIV test cost approximately £135 with a range over time and
across sites of £85-£175. The cost per test varied by the volume of users attending the
site and, over time as the volume of users increased, the cost per test fell. There was a
trend towards increasing efficiency through the lifetime of the pilot. 
More data is needed from THT and other HIV testing services to allow comparative
analysis with the cost of traditional HIV testing interventions in GUM, primary care and
ante-natal services.
5.3 ACCESS
The users of the fasTest interventions were a function of their promotion; the need to
establish HIV status in the local population; and pre-existing service provision in the
locality of the site (ie. the availability and accessibility of comparable HIV testing
services). It is feasible to attract both Gay and Bisexual men and Black African migrants
into fasTest services, though promotion to African and other Black and minority ethnic
populations needs careful consideration. 
Our interim comparisons with standard GUM in Bristol suggest users are more ethnically
diverse and at higher risk of having undiagnosed HIV. The addition of fasTest
interventions certainly expands capacity and choice so long as they do not replace pre-
existing HIV testing services.
5.4 ACCEPTABILITY
More than a third (41.2%) of all testers had never previously tested for HIV, among which
one-in-seven (14.8%) said they had never tested for HIV before because they had not
known where to get tested. 
More than half (50.2%) of all respondents using fasTest reported that their main reason
for choosing fasTest over other options for HIV testing was because the test result is
available at the same visit. Another third (32.7%) of all respondents stated that it is more
convenient to come here. This answer was assumed to refer to both the ‘after hours’
nature of the service and the absence of any need for an appointment. It could also
include the physical setting of the intervention (ie. not out-patients in a hospital or
primary care) though this was rarely mentioned. 
Interim analysis of the first seven completed interviews with people testing HIV positive in
fasTest suggest that overall satisfaction with the fasTest service is very high, as is
satisfaction with referral pathways into standard HIV care. 
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5.5 NEED
During the evaluation period these three fasTest pilot sites recruited at least 678 people
who wanted to know their HIV status. During the evaluation period, 593 people tested for
HIV in these three pilot sites and completed our evaluation questionnaire. Among these 17
received a new HIV positive diagnosis at an overall HIV prevalence of 2.9%. Of these 17
positives, 15 received a confirmatory HIV positive diagnosis on serology. A very similar
HIV prevalence was observed in the monitoring data of the pilot period (see section 2.4).
HIV prevalence varied by gender, sexuality and ethnicity. Compared to heterosexuals, Gay
and Bisexual men had a much higher HIV prevalence (4.3%, 13/299). This varied by
fasTest site with a prevalence among Gay and Bisexual men of 3.2% (3/93) in Leeds;
3.8% (2/53) in Bristol; and 5.2% (8/153) in Lighthouse South London. Prevalence also
varied by ethnicity among Gay and Bisexual men: 3.9% (8/203) of White British men
tested positive compared to 5.5% (3/55) of White other men. While the sample size was
very small, Black African (17%, 1/6) Gay and Bisexual men had the highest HIV
prevalence of all the sub-groups. One other Gay man of South East Asian ethnicity also
tested positive for HIV. 
Among heterosexuals an HIV prevalence of 1.0% was observed for males (2/195) and
2.2% for females (2/91), giving an overall rate of 1.4% (4/286). Prevalence varied by
fasTest site for both male and female heterosexuals. In Bristol none of the 63
heterosexuals testing were diagnosed positive, compared to 1.0% (1/100) in Lighthouse
South and 2.4% (3/123) in Leeds. Prevalence also varied by ethnicity among
heterosexuals. The two heterosexual males testing positive were Black African and Black
Caribbean respectively. The two female heterosexuals testing positive were Black African
and mixed ethnicity: white and Black African respectively. None of the 178 White British
heterosexuals tested at these three sites had undiagnosed HIV
There is very limited evidence to address the question of whether fasTest diagnoses
people any earlier in their disease history. From the full serology results of 14 new fasTest
positives the mean initial CD4 was 485 (sd 267; median 458; range 11-946) and the
mean initial viral load was 97,144 (sd. 99,323; median 69,300; range 228-367,000). 
5.6 EFFECTIVENESS
During the evaluation period, 662 people tested for HIV in three fasTest pilot sites. Among
these 20 received a new HIV positive diagnosis at an overall HIV prevalence of 3.0%. Of
these 20 positives, 13 entered HIV care in the host clinic associated with the fasTest site
and 3 others were known to have attended for HIV care elsewhere. While the other 4 may
have entered care no information was available on where they did so. 
5.7 EFFICIENCY
None of the clinics ran at full capacity for the entire pilot period but managing
(over)demand was problematic at times in all sites. Overall, on average 1 HIV test was
delivered for 53 minutes of clinical staff time with a range from 79 minutes of clinical staff
time per test in Bristol; 64 minutes in Leeds and 32 minutes in London Lighthouse South. 
Promotion of the service affected uptake but more expensive methods of promotion
(including dedicated outreach) do not appear to have a disproportionate impact on
uptake. 
[ends]
